NKTR
Nektar Therapeutics
41.20$
+0.9%
vs. previous close
Closing price · As of: Oct 9, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 19.4% | 17.6% | 24.8% | 26.0% | 3.7% | 10.2% | 17.5% | 0.5% | 17.2% | 18.7% | 19.3% | 21.5% | 16.9% | 17.7% | 7.5% | 11.8% | 18.5% | 18.4% | 24.3% | 27.1% | 21.3% | 24.6% | 21.4% | 23.7% | 21.0% | 28.3% | 32.7% | 34.1% | 51.5% | 30.5% | 39.4% | 41.5% | 18.4% | 27.3% | 4.1% | 1.9% | 1.7% | 0.0% | 1.4% | – | – | |
| 80.6% | 82.4% | 75.2% | 74.0% | 96.3% | 89.8% | 82.5% | 99.5% | 82.8% | 81.3% | 80.7% | 78.5% | 83.1% | 82.3% | 92.5% | 88.2% | 81.5% | 81.6% | 75.7% | 72.9% | 78.7% | 75.4% | 78.6% | 76.3% | 79.0% | 71.7% | 67.3% | 65.9% | 48.5% | 69.5% | 60.6% | 58.5% | 81.6% | 72.7% | 100.0% | 100.0% | 98.3% | 100.0% | 98.6% | 100.0% | 99.4% | |
| 143.0% | 134.1% | 246.9% | 174.2% | 43.0% | 85.3% | 261.5% | 8.1% | 370.6% | 273.4% | 419.8% | 457.6% | 339.0% | 325.9% | 215.5% | 197.4% | 334.7% | 437.8% | 404.3% | 357.6% | 416.3% | 398.3% | 432.1% | 198.0% | 142.2% | 157.7% | 141.1% | 144.8% | 99.7% | 125.4% | 126.7% | 126.5% | 145.2% | 98.5% | 291.4% | 267.4% | 231.1% | 136.2% | 328.5% | 386.2% | 241.4% | |
| 28.2% | 34.1% | 48.4% | 46.2% | 7.9% | 12.9% | 49.2% | 1.9% | 67.4% | 59.7% | 88.6% | 96.9% | 82.1% | 80.2% | 51.8% | 49.8% | 89.8% | 115.7% | 134.0% | 104.3% | 118.2% | 128.5% | 110.1% | 95.1% | 95.4% | 99.6% | 97.6% | 87.2% | 87.6% | 72.5% | 93.1% | 87.3% | 78.6% | 58.7% | 232.8% | 152.8% | 134.6% | 52.2% | 123.7% | 126.0% | 97.9% | |
| 171.2% | 168.2% | 295.3% | 220.5% | 50.9% | 98.2% | 310.7% | 10.0% | 438.1% | 333.1% | 508.4% | 554.4% | 421.1% | 406.1% | 267.3% | 247.3% | 424.6% | 553.5% | 538.3% | 461.9% | 534.5% | 526.8% | 542.2% | 293.1% | 237.6% | 257.4% | 691.1% | 312.7% | 234.3% | 209.8% | 224.3% | 270.4% | 224.0% | 23.5% | 525.8% | 424.2% | 365.8% | 187.5% | 450.9% | 517.9% | 339.7% | |
| -90.5% | -85.8% | -220.1% | -146.5% | 45.4% | -25.2% | -228.2% | 89.5% | -355.3% | -251.8% | -427.6% | -476.0% | -337.9% | -323.8% | -174.9% | -159.1% | -343.1% | -471.9% | -462.6% | -389.0% | -455.8% | -451.5% | -463.6% | -216.8% | -158.6% | -185.7% | -623.8% | -246.8% | -185.8% | -140.3% | -163.7% | -211.9% | -142.4% | 49.2% | -425.8% | -324.2% | -267.4% | -87.5% | -352.3% | -417.9% | -240.4% | |
| 28.9% | 27.6% | 40.3% | 29.0% | 6.5% | 11.5% | 27.2% | 1.0% | 36.9% | 29.6% | 40.0% | 48.1% | 38.5% | 37.3% | 26.0% | 15.0% | 28.1% | 34.9% | 56.2% | 46.2% | 51.4% | 32.5% | 30.3% | 33.5% | 29.4% | 32.7% | 29.7% | 30.0% | 24.5% | 28.8% | 25.6% | 27.3% | 25.0% | 34.8% | 47.6% | 48.3% | 51.3% | 44.8% | 73.1% | 71.1% | 56.7% | |
| -118.6% | -111.5% | -257.7% | -172.8% | 39.9% | -35.2% | -251.3% | 89.7% | -349.6% | -251.2% | -423.4% | -472.6% | -337.1% | -330.4% | -273.8% | -163.5% | -361.5% | -499.0% | -519.6% | -441.8% | -520.0% | -582.4% | -363.7% | -736.5% | -250.6% | -256.7% | -634.8% | -249.6% | -190.1% | -176.3% | -170.2% | -222.7% | -153.6% | 24.0% | -485.9% | -373.9% | -301.6% | -165.3% | -412.9% | -397.8% | -287.1% | |
| 0.4% | 1.2% | 0.5% | 0.3% | 0.1% | 0.2% | 0.7% | 0.4% | -3.2% | -4.6% | -3.5% | -1.2% | 1.1% | 0.8% | 0.4% | 0.3% | 0.1% | 0.5% | 0.4% | 1.3% | 0.4% | 0.0% | 0.5% | 0.5% | -0.7% | 14.3% | -0.3% | -0.2% | -0.3% | -0.1% | -0.2% | 0.2% | 0.0% | -0.9% | 0.5% | -1.7% | -0.3% | 0.1% | 0.6% | 0.0% | 0.1% | |
| -119.0% | -112.7% | -258.3% | -173.1% | 39.8% | -35.4% | -252.0% | 89.3% | -346.3% | -246.6% | -419.9% | -471.4% | -338.2% | -331.2% | -274.2% | -163.8% | -361.6% | -499.5% | -520.0% | -443.1% | -520.5% | -582.4% | -364.2% | -736.9% | -249.9% | -271.0% | -634.5% | -249.4% | -189.8% | -176.2% | -170.1% | -222.9% | -153.6% | 24.9% | -486.4% | -372.2% | -301.3% | -165.4% | -413.4% | -401.0% | -287.8% | |
| -79.0% | -73.6% | -201.2% | -131.5% | 49.0% | -21.0% | -217.3% | 90.9% | -302.9% | -213.9% | -372.5% | -411.4% | -286.8% | -282.6% | -238.8% | -141.9% | -322.6% | -450.3% | -448.4% | -383.1% | -454.1% | -540.7% | -318.3% | -687.0% | -209.8% | -213.4% | -594.5% | -209.0% | -158.6% | -140.6% | -137.2% | -189.2% | -124.5% | 59.9% | -391.7% | -302.3% | -248.6% | -119.6% | -338.3% | -416.9% | -246.2% |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.